• Asma Rashid
  • Rukhshan Khurshid
  • Aiza Latif
  • Nazifa Ahmad
  • Latif Aftab


Background: Osteoporosis has emerged a major health hazard in postmenopausal women. Theprocess of osteoporosis accelerates two year prior to menopause, reaching the peak level during first3 years of menopause when women loss 3‒5% of their bone mass per year. This study tried to findout the role of phytoestrogne in improving the bone mineral density and bone related biochemicalparameters in group of postmenopausal women. Methods: Fifty postmenopausal women with agerange 50‒60 years were included in the study. Phytoestrogen with mineral supplement were giventwice daily for 3 months. Biochemical parameters like serum calcium, magnesium, alkalinephosphatase, uric acid, total protein and oestrogen were determined before and after phytoestrogentherapy by autoanalyser and ELIZA (oestrogen assay). T-score before and after phytoestrogen werefind out by densitometer DEXA. Results: The level of serum calcium, magnesium, uric acid andoestrogen was increased in women after taking phytoestrogen but significant difference (p<0.01) wasonly observed in case of serum calcium. Level of serum alkaline phosphatase and total serum proteinwere slightly increased with no significant different before and after phytoestrogen therapy. Value ofT-score was although markedly decreased after phytoestrogen therapy but it showed no significantdifference. Conclusion: It is concluded that as the early years of menopause are a period of rapidbone loss, and the risk for osteoporosis increases substantially, the habitual intake of soy protein andisoflavones may play a role in the retardation of bone loss.Keywords: Osteoporosis, Phytoestrogen, Postmenopausal status


NIH consensus development panel on osteoporosis prevention,

diagnosis and therapy. South Med J 2001;94:569–73.

Sowers MF, Galuska, DA. Epidemiology of bone mass in

premenopausal women. Epidemiol Rev 1993;15:374–98.

Raisz L. Pathogenesis of osteoporosis: concepts, conflicts, and

prospects. J Clin Invest 2005;115:3318–25.

Crans GG, Silverman SL, Genant HK, Glass EV, Krege JH.

Association of severe vertebral fractures with reduced quality

of life. Arthritis Rheum 2004;50:4028–34.

Baig L, Mansuri FA, Karim SA. Association of menopause

with osteopenia and osteoporosis results from population based

study done in Karachi. J Coll Physicians Surg Pak


El-Hajj Fuleihan G. Osteoporosis: an overview of practice

guidelines for bone density measurements and osteoporosis

treatment strategies. Leb Med J 1999;47:221–8.

Khan AA, Syed Z. Bone densitometry in premenopausal women:

synthesis and review. J Clin Densitom 2004;7(1):85–92.

Mann GB, Kang YC, Brand C, Ebeling PR, Miller JA.

Secondary causes of low bone mass in patients with breast

cancer: a need for greater vigilance. J Clin

Oncol 2009;18(4):85–9.

Vatanparast H, Chilibeck PD. Does the effect of soy

phytoestrogens on bone in postmenopausal women depend on the

equol-producing phenotype? Nutr Rev 2007;65(6 Pt-1):294–9.

Ho SC, Chan AS, Ho YP, So EK, Sham A, Zee B, Woo JL.

Effects of soy isoflavone supplementation on cognitive function

in Chinese postmenopausal women: a double-blind, randomized,

controlled trial. Menopause 2007;14(3 Pt 1):489–99.

Bacciottini L, Falchetti A, Pampaloni B, Bartolini E, Carossino

AM, Brandi ML. Phytoestrogens: food or drug? Clin Cases

Miner Bone Metab 2007;4(2):123–30.

Wuttke W, Jarry H, Seidlova-Wuttke D. Isoflavones--safe food

additives or dangerous drugs? Ageing Res Rev 2007;6(2):150–88.

Drews K, Seremak-Mrozikiewicz A, Puk E, KalubaSkotarczak A, Malec M, Kazikowska A. The safety and

tolerance of isoflavones (Soyfem) administration in

postmenopausal women. Ginekol Pol 2007;78:361–5.

Button BJ and Patel N. Phytoestrogens for Osteoporosis. Clin

Rev Bone Mineral Metab 2004;2:341–56.

Gris Martínez JM. Isoflavones in menopause women. Med

Clin (Barc) 2006;127:352–6.

J Ayub Med Coll Abbottabad 2010;22(3)

Sehmisch S, Erren M, Kolios L, Tezval M, Seidlova-Wuttke D,

Wuttke W, et al. Effects of isoflavones equol and genistein on

bone quality in a rat osteopenia model. Phytother Res

;24(Suppl 2):S168–74.

Dong J, Huang ZW, Piao JH, Li F, Zeng J, Gong J, Yang XG.

Relationship between estrogen receptor gene Px haplotype and

the effect of calcium and soy isoflavone supplementation on

bone mineral density of Chinese postmenopausal women.

Zhonghua Yu Fang Yi Xue Za Zhi 2008;42:329–34.

Heaney RP, Recker RR, Watson P, Lappe JM Phosphate and

carbonate salts of calcium support robust bone building in

osteoporosis. Am J Clin Nutr 2010;92:101–5.

Wilkin TJ. Changing perceptions in osteoporosis. BMJ


Black DM, Steinbuch M, Palermo L, Dargent-Molina P,

Lindsay R, Hoseyni MS, et al. An Assessment Tool for

Predicting Risk in Postmenopausal Women. Osteoporos Int


Ye YB, Tang XY, Verbruggen MA, Su YX. Soy isoflavones

attenuate bone loss in early postmenopausal Chinese women: a

single-blind randomized, placebo-controlled trial. Eur J Nutr


Fragakis AS. The Health Professional's Guide to Popular

Dietary Supplements. 2nd edition. Chicago IL: American

Dietetic Association; 2003.

Arjmandi BH, Getunger MJ, Goyal NV, Alekel L, Hasler CM,

Juna S, et al. The role of soy protein with normal or reduced

isoflavones content in reversing ovarian hormone deficiency

induced bone loss in rats. Am J Clin Nutr 1998;68:1358S–63S.

Aydin H, Deyneli O, Yavuz D, Gözü H, Mutlu N, Kaygusuz I,

Akalin S. Short-term oral magnesium supplementation

suppresses bone turnover in postmenopausal osteoporotic

women. Biol Trace Elem Res 2010;133:136–43.

Guo K, Zhang B, Chen C, Uchiyama S, Ueno T, Chen Y, Su

Y. Daidzein-metabolising phenotypes in relation to serum

lipids and uric acid in adults in Guangzhou, China. Br J Nutr


Pacifici R. Estrogen, cytokines, and pathogenesis of

postmenopausal osteoporosis. J Bone Mineral Res


Knight DC, Eden JA. A review of the clinical effects of

phytoestrogens. Obstet Gynecol 1996;87:897–904.

Albertazzi P, Purdie DW. The nature and utility of the

phytoestrogens, a review of the evidence. Maturitas


Brzezinski A, Debi A. Phytoestrogens, the “natural” selective

estrogen receptor modulators? Eur J Obstet Gynecol Reprod

Biol 1999;85:47–51.

Gruber CJ, Tschugguel W, Schneeberger C, Huber JC.

Production and action of estrogens. N Engl J Med


Mihalache G, Mihalache GD, Indrei LL, Indrei A, Hegsted M.

Phytoestrogens role in bone functional structure protection in

the ovariectomized rat. Rev Med Chir Soc Med Nat Iasi


Wober J, Weisswange I, Vollmer G. Stimulation of alkaline

phosphatase activity in Ishikawa cells induced by various

phytoestrogens and synthetic estrogens. J Steroid Biochem Mol

Biol 2002;83(1–5):227–33.

Bolli A, Marino M, Rimbach G, Fanali G, Fasano M, Ascenzi

P. Flavonoid binding to human serum albumin. Biochem

Biophys Res Commun 2010;398:444–9.

Henriksen K, Tanko LB, Qvist P, Delmas PD, Christiansen C,

Karsdal MA. Assessment of osteoclast number and function:

application in the development of new and improved treatment

modalities for bone diseases. Osteoporos Int 2007;18:681–5.

Choi EM, Suh KS, Kim YS, Choue RW, Koo SJ. Soybean

ethanol extarc increases the function of osteoblastic MC3T3-E1

cells. Phytochemistry 2001;56:733–9.

Sugimoto T, Nishiyama K, Kuribayashi F, Chihara K. Serum

levels of insulin-like growth factor (IGF) I, IGFbinding protein

(IGFBP)-2, and IGFBP-3 in osteoporotic patients with and

without spinal fractures. J Bone Mineral Res 1997;12:1272–6.

Hsu CS, Shen WW, Hsueh YM, Yeh SL. Soy iso.avone

supplemention in postmenopausal women. Effects on plasma

lipids, antioxidant enzyme activities and bone density. J Reprod

Med 2001;46:221–6.

Benlhabib E, Baker JI, Keyler DE, Singh AK. Composition,

red blood cell uptake, and serum protein binding of

phytoestrogens extracted from commercial kudzu-root and soy

preparations. J Med Food 2002;5(3):109–23.




Most read articles by the same author(s)